Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 195

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Prognostic impact of SNP array karyotyping in myelodysplastic syndromes and related myeloid malignancies

Open access
Tiu, Ramon V., Gondek, Lukasz P., O'Keefe, Christine L., Elson, Paul, Huh, Jungwon, Mohamedali, Azim, Kulasekararaj, Austin, Advani, Anjali S., Paquette, Ronald, List, Alan F., Sekeres, Mikkael A., McDevitt, Michael A., Mufti, Ghulam J., Maciejewski, Jaroslaw P. · 2011 · Blood

Abstract

Single nucleotide polymorphism arrays (SNP-As) have emerged as an important tool in the identification of chromosomal defects undetected by metaphase cytogenetics (MC) in hematologic cancers, offering superior resolution of unbalanced chromosomal defects and acquired copy-neutral loss of heterozygosity. Myelodysplastic syndromes (MDSs) and related cancers share recurrent chromosomal defects and molecular lesions that predict outcomes. We hypothesized that combining SNP-A and MC could improve diagnosis/prognosis and further the molecular characterization of myeloid malignancies. We analyzed MC/SNP-A results from 430 patients (MDS = 250, MDS/myeloproliferative overlap neoplasm = 95, acute myeloid leukemia from MDS = 85). The frequency and clinical significance of genomic aberrations was compared between MC and MC plus SNP-A. Combined MC/SNP-A karyotyping lead to higher diagnostic yield of chromosomal defects (74% vs 44%, P < .0001), compared with MC alone, often through detection of novel lesions in patients with normal/noninformative (54%) and abnormal (62%) MC results. Newly detected SNP-A defects contributed to poorer prognosis for patients stratified by current morphologic and clinical risk schemes. The presence and number of new SNP-A detected lesions are independent predictors of overall and event-free survival. The significant diagnostic and prognostic contributions of SNP-A–detected defects in MDS and related diseases underscore the utility of SNP-A when combined with MC in hematologic malignancies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1182/blood-2010-07-295857

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

See all 195

Metadata

Authors
Tiu, R. V., Gondek, L. P., O'Keefe, C. L., Elson, P., Huh, J., Mohamedali, A., Kulasekararaj, A., Advani, A. S., Paquette, R., List, A. F., Sekeres, M. A., McDevitt, M. A., Mufti, G. J., & Maciejewski, J. P.
Venue
Blood
Published
2011-04-28
Volume
117
Issue
17
Pages
4552-4560
ISSN
  • 0006-4971 (ISSN-L)
  • 1528-0020
OpenAlex
W1994924914
Cited by
195
References
6
FWCI
16.60
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Prognostic impact of SNP array karyotyping in myelodysplastic syndromes and related myeloid malignancies. https://app.cochat.ai/papers/10.1182/blood-2010-07-295857
The paper
Tiu, R. V., Gondek, L. P., O'Keefe, C. L., Elson, P., Huh, J., Mohamedali, A., Kulasekararaj, A., Advani, A. S., Paquette, R., List, A. F., Sekeres, M. A., McDevitt, M. A., Mufti, G. J., & Maciejewski, J. P. (2011). Prognostic impact of SNP array karyotyping in myelodysplastic syndromes and related myeloid malignancies. Blood. https://doi.org/10.1182/blood-2010-07-295857

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.